Patents by Inventor Thomas Du

Thomas Du has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120034242
    Abstract: The present invention in all of its associated aspects provides improved methods and compositions for treating cancer in a mammal based on the administration of the combination of a cytokine-expressing cellular vaccine and at least one additional cancer therapeutic agent or treatment to a patient with cancer, wherein administration of the combination results in enhanced therapeutic efficacy relative to administration of the cytokine-expressing cellular vaccine or cancer therapeutic agent or treatment as a monotherapy.
    Type: Application
    Filed: July 12, 2011
    Publication date: February 9, 2012
    Applicant: BIOSANTE PHARMACEUTICALS, INC.
    Inventors: Karin Jooss, Jennifer Creson, Betty Li, Rodney Prell, Sandra Aung, Marina Boris Moskalenko, Thomas Du
  • Publication number: 20070231298
    Abstract: The present invention in all of its associated aspects provides improved methods and compositions for treating cancer in a mammal based on the sequential administration of the combination of a cytokine-expressing cancer immunotherapy composition and at least one tyrosine kinase inhibitor, wherein administration of the combination results in enhanced therapeutic efficacy relative to administration of the cytokine-expressing cancer immunotherapy composition or at least one tyrosine kinase inhibitor as a monotherapy.
    Type: Application
    Filed: March 27, 2007
    Publication date: October 4, 2007
    Applicant: Cell Genesys, Inc.
    Inventors: Betty Li, Thomas Du, Karin Jooss
  • Publication number: 20050002916
    Abstract: The present invention in all of its associated aspects provides improved methods and compositions for treating cancer in a mammal based on the administration of the combination of a cytokine-expressing cellular vaccine and at least one additional cancer therapeutic agent or treatment to a patient with cancer, wherein administration of the combination results in enhanced therapeutic efficacy relative to administration of the cytokine-expressing cellular vaccine or cancer therapeutic agent or treatment as a monotherapy.
    Type: Application
    Filed: March 24, 2004
    Publication date: January 6, 2005
    Inventors: Karin Jooss, Jennifer Creson, Betty Li, Rodney Prell, Sandra Aung, Marina Moskalenko, Thomas Du